Ketalar 50 MG/ML Injectable Solution

DRUG2 trials

Sponsors

University of Liege, Aksaray University Training and Research Hospital

Conditions

Disorder of ConsciousnessSedation Complication

Phase 2

Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

RecruitingNCT05343507

University of LiegeDisorder of Consciousness

Start: 2022-05-01End: 2026-05-01Target: 30Updated: 2022-11-07

Unknown Phase

Comparison of Emergence/Dysphoric Reaction Frequency of Using 2 Different Doses Ketamine

CompletedNCT05786365

Aksaray University Training and Research HospitalSedation Complication

Start: 2023-01-01End: 2023-12-31Updated: 2024-07-30